Eva Conde García

Title: Eva Conde García: Innovator in Immunogenic Products

Introduction

Eva Conde García is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of immunogenic products. Her work focuses on addressing disorders associated with aberrant expression or activity of interleukins, specifically IL-4 and IL-13.

Latest Patents

Eva Conde García holds a patent for an immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL-13 expression or activity. This innovative product includes a cytokine conjugated with a carrier protein, where the cytokine is selected from IL-4, IL-13, and mixtures thereof. The carrier protein used in this formulation is CRM. Additionally, her patent outlines a method for manufacturing the immunogenic product and its therapeutic use for treating inflammatory disorders linked to abnormal IL-4 and/or IL-13 expression or activity. She has 1 patent to her name.

Career Highlights

Throughout her career, Eva has worked with notable organizations such as Neovacs and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Eva has collaborated with esteemed colleagues, including Géraldine Grouard-Vogel and Romain Bertrand. These partnerships have enriched her work and fostered innovation in her field.

Conclusion

Eva Conde García is a trailblazer in the development of immunogenic products, with a focus on treating inflammatory disorders. Her contributions to immunology and her collaborations with other professionals highlight her commitment to advancing medical science.